Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Axiom Therapeutics

Request full access

AI-powered covalent drug discovery for untreatable cancers

London, United KingdomFounded 2024Biotech & Life Sciences

About Axiom Therapeutics

Axiom Therapeutics is a London-based biotechnology company pioneering a new class of precision oncology treatments. Founded in 2024 by University of Cambridge alumni Ryan Geiser and Chris Haggard, the company leverages a proprietary platform that combines machine learning with physics-based simulations to unlock "undruggable" cancer targets.

The company’s core technology is an AI-driven discovery engine designed specifically for covalent inhibitors—drugs that form permanent bonds with their target proteins. by integrating quantum simulation methods with advanced machine learning, Axiom predicts the interaction between small molecules and disease-causing proteins with high accuracy, enabling the design of more potent and selective therapies for hard-to-treat malignancies.

Axiom aims to revolutionize cancer care by identifying novel therapeutic solutions for patients who currently lack effective treatment options. Backed by investors like Cambridge Enterprise Ventures and Plug and Play, the startup is accelerating the development of next-generation medicines that target the underlying molecular drivers of disease.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
81.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Drug Development, Research and Development, Molecular, Spinout, AI Drug Discovery
Technology
Artificial Intelligence, Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Apr 2025 $15M $60M Dimension Capital Management · Amplify Partners · Zetta Venture Partners · Fenwick & West ↗
SPINOUT✓Other financing Aug 2024 $0 — University of Cambridge ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Axiom Therapeutics website traffic

Latest recorded traffic for Axiom Therapeutics is 3.1K monthly website visits, up 5066.7% over the last three months. Axiom Therapeutics's team grew 33.3% over the past year.

Latest monthly visits3.1K 3-month web change+5066.7% 1-year team growth+33.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Axiom Therapeutics in the London ecosystem

Live from Dealroom

The Axiom Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Dimension Capital Management
  • Amplify Partners
  • Zetta Venture Partners
  • Fenwick & West

Other known investors5 additional known investors

  • University of Cambridge
  • Grow London
  • Lunar Ventures
  • Samos Investments
  • Verve Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Axiom Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Axiom Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.